Tye-1001

N/A

Report date: 2025/03/07 15:01:08
First In Class

Base Information

Drug NameTye-1001
Drug Alias NameTye-1001TYE1001TYE-1001
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Tyercan Bio-pharm Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShenzhen Tyercan Bio-pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungStomach Neoplasms +[4] 
Inactive IndicationsNasopharyngeal Carcinoma

Other Information

ATC CodeN/A
Related LinksN/A